Bayer AG, Procter&Gamble and Fresenius Kabi Austria GmbH are Dominating the Laxative Market in 2020

Laxative Market is expected to grow with the CAGR of 5.8% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-laxative-market

Global laxative market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Laxative market are introducing strong range of product portfolio and OTC laxatives. This helped companies to maximize the sales with enhanced reprocessed services and product portfolio. For instance, In January 2020, Fresenius Kabi Austria GmbH had launched a new website about detailed information about the use of laxatives. The lactulose laxative laevolac is a synthetic laxative, used to cure constipation. The website launched would result in increased awareness about the use of lactulose laxative among consumers, rise in purchase power and enhancement in product portfolio and increase in net sales.

Bayer AG is the dominating player in global laxative market. The other key players existing in the market are Stryker, General Electric, Johnson & Johnson Services, Inc., 3M, Cantel Medical, Olympus Corporation, STERIS, Medline Industries, Inc., Medtronic, EverX, Vanguard AG, Avante Health Solutions, SteriPro, Getinge AB, SureTek Medical, SOMA TECH INTL, NEScientific, Inc., Cardinal Health, Renu Medical (a subsidiary of Arjo), INNOVATIVE HEALTH among others.

Laxative MarketBayer AG

Bayer AG has it base headquarters in Leverkusen, Germany The company is focused on creating values for the customers, stockholders and employees while boosting the company’s earning power. The company deals in business segments such as Crop Science, Pharmaceuticals and Consumer Health out of which Consumer Health is the market focused market focused segment.

  • In January 2018, Bayer AG had introduced MiraLAX, the popular drug for constipation. MiraLAX had received the reprieve from the Food and Drug Administration (FDA). The Food and Drug Administration had stated that the drug will be used for another 6 months.

The company has presence in North America, Europe, Asia Pacific, Middle East and Africa, New Zealand and Latin America.  The company has subsidiaries in Bayer Algeria S.P.A. (Algeria), Bayer S.A. (Argentina), Monsanto Argentina SRL (Argentina), Bayer Crop Science Holdings Pty Ltd (Australia), Bayer Crop Science Ltd (Bangladesh).

Procter&Gamble

Procter & Gamble is headquartered in Ohio, the U.S. and was founded in 1837. The aim of the company is to provide high quality branded product and services that will improve the living conditions of the consumers. The business segments are fabric and home care, baby products, feminine and family care, health care and grooming; out of which health care is the market focused segment. The company has product categories such as oral care, personal health care, home care, skin care and personal care, hair care grooming, baby care, feminine care and family care out of which personal health care is the market focused category.  

  • In January 2012, Meta Mucil, a brand of Procter & Gamble was introduced during the Heart Health Month conference. The doctors explained the complete importance of Meta Mucil as a fiber supplement. Meta Mucil is used to improve dietary health. The product Meta Mucil was manufactured and distributed to pharmaceutical retail stores and hospital pharmaceutical stores. It had increased the purchase power of customers. Doctors had recommended Meta Mucil to heart patients. It improved the product range and delivered a linear growth in the market.

The company has wide global presence across Asia Pacific, North America, Europe, Middle East and Africa and Latin America The company has various subsidiaries which the Gillette company (U.S.), Braun (Germany), Procter & Gamble Hygiene and Health Care (India), Duracell(U.S.), Gillette India Ltd (India) among others

Fresenius Kabi Austria GmbH (A subsidiary of Fresenius Kabi AG)

Fresenius Kabi Austria GmbH is headquartered in Homburg, Germany and was founded in year 1999. The global healthcare company is engaged in specialization of life saving medicines and trechnologies for infusion, transfusion and clinical nutrition. The business segments are Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. Fresenius Kabi is the market focused segment.  The company offers wide range of product categories such as lactulose, pharma and food out of which lactulose is market focused category.

  • In January 2020, Fresenius Kabi Austria GmbH had launched a new website about detailed information about the use of laxatives. The lactulose laxative laevolac is a synthetic laxative, used to cure constipation. The website launched would result in increased awareness about the use of lactulose laxative among consumers, rise in purchase power and enhancement in product portfolio and increase in net sales.

The company has wide global presence across the world in Europe, North America, Asia Pacific, Middle East and Africa The subsidiaries are Fresenius Kabi Australia Pty Ltd (Australia). Fresenius Kabi Brasil Ltd (Brazil), Fresenius Kabi Norge As (Norway),  PT. ETHICA Industri Farmasi (Indonesia) among others.